CA8 Gene Cerebellar Ataxia and Mental Retardation with or without Quadrupedal Locomotion Type 3 Genetic Test sale cost 4400 AED
ASPA Gene Canavan Disease Genetic Test sale cost 4400 AED ASPA Gene Canavan Disease Genetic Test Cost 5,600 د.إ Original price was: 5,600 د.إ.4,400 د.إCurrent price is: 4,400 د.إ.
VLDLR Gene Cerebellar Hypoplasia and Mental Retardation with or without Quadrupedal Locomotion Type 1 Genetic Test sale cost 4400 AED VLDLR Gene Cerebellar Hypoplasia and Mental Retardation with or without Quadrupedal Locomotion Type 1 Genetic Test Cost 5,600 د.إ Original price was: 5,600 د.إ.4,400 د.إCurrent price is: 4,400 د.إ.
Sale!

CA8 Gene Cerebellar Ataxia and Mental Retardation with or without Quadrupedal Locomotion Type 3 Genetic Test Cost

Original price was: 5,600 د.إ.Current price is: 4,400 د.إ.

-21%

The “CA8 Gene Cerebellar Ataxia and Mental Retardation with or without Quadrupedal Locomotion Type 3 Genetic Test” is a specialized diagnostic tool offered by DNA Labs UAE, aimed at identifying mutations in the CA8 gene. These mutations are associated with a rare neurological disorder that can manifest as cerebellar ataxia, mental retardation, and in some cases, an unusual pattern of movement that may include quadrupedal locomotion. Cerebellar ataxia refers to a lack of muscle control or coordination of voluntary movements, which stems from problems in the cerebellum, the part of the brain that controls muscle coordination.

The test, priced at 4400 AED, involves analyzing the patient’s DNA to detect abnormalities in the CA8 gene that could confirm the diagnosis of this condition. This genetic testing is crucial for families seeking to understand the genetic basis of the disorder, which can aid in managing the condition, anticipating its progression, and making informed decisions about care. Additionally, it can provide essential information for genetic counseling, especially for those planning to have children and concerned about passing on genetic conditions.

DNA Labs UAE, a leading facility in genetic testing, employs advanced technologies and methodologies to ensure accurate and reliable results. The test is conducted under the strictest standards of quality and confidentiality, ensuring that patients receive comprehensive support throughout the testing process.

Home  Sample collection service available

  • 100% accuaret Test Results
  • Ranked as Most trusted Genetic DNA Lab
  • This test is not intended for medical diagnosis or treatment
Guaranteed Safe Checkout

CA8 Gene Cerebellar Ataxia and Mental Retardation with or without Quadrupedal Locomotion Type 3 Genetic Test

At DNA Labs UAE, we offer the CA8 Gene Cerebellar Ataxia and Mental Retardation with or without Quadrupedal Locomotion Type 3 Genetic Test. This test is designed to identify mutations in the CA8 gene, which are associated with cerebellar ataxia and mental retardation with or without quadrupedal locomotion type 3 (CAMRQ3).

CAMRQ3 is a rare genetic disorder characterized by delayed motor development, intellectual disability, and difficulty with balance and coordination. By using next-generation sequencing (NGS) technology, our test can analyze multiple genes at once, providing a comprehensive analysis of an individual’s genetic makeup.

Test Name: CA8 Gene Cerebellar Ataxia and Mental Retardation with or without Quadrupedal Locomotion Type 3 Genetic Test

  • Components: CA8 Gene Cerebellar Ataxia and Mental Retardation with or without Quadrupedal Locomotion Type 3 Genetic Test
  • Price: 4400.0 AED
  • Sample Condition: Blood or Extracted DNA or One drop Blood on FTA Card
  • Report Delivery: 3 to 4 Weeks
  • Method: NGS Technology
  • Test Type: Neurological Disorders
  • Doctor: Neurologist
  • Test Department: Genetics
  • Pre Test Information: Clinical History of Patient who is going for CA8 Gene Cerebellar Ataxia and Mental Retardation with or without Quadrupedal Locomotion Type 3 NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with CA8 Gene Cerebellar Ataxia and Mental Retardation with or without Quadrupedal Locomotion Type 3

An identification of a CA8 gene mutation through this test can aid in the diagnosis of CAMRQ3 and provide information about the inheritance pattern of the disorder. This information can be valuable for genetic counseling and family planning.

Early diagnosis and management of CAMRQ3 can significantly improve outcomes and quality of life for affected individuals. Treatment may involve physical therapy, speech therapy, and educational interventions tailored to the individual’s specific needs.

Test Name CA8 Gene Cerebellar ataxia and mental retardation with or without quadrupedal locomotion type 3 Genetic Test
Components
Price 4400.0 AED
Sample Condition Blood or Extracted DNA or One drop Blood on FTA Card o
Report Delivery 3 to 4 Weeks
Method NGS Technology
Test type Neurological Disorders
Doctor Neurologist
Test Department: Genetics
Pre Test Information Clinical History of Patient who is going for CA8 Gene Cerebellar ataxia and mental retardation with or without quadrupedal locomotion type 3 NGS Genetic DNA Test A Genetic Counselling session to draw a pedigree chart of family members affected with CA8 Gene Cerebellar ataxia and mental retardation with or without quadrupedal locomotion type 3
Test Details

CA8 gene mutations are associated with cerebellar ataxia and mental retardation with or without quadrupedal locomotion type 3 (CAMRQ3). CAMRQ3 is a rare genetic disorder characterized by delayed motor development, intellectual disability, and difficulty with balance and coordination.

NGS genetic testing can be used to identify mutations in the CA8 gene. This type of testing uses next-generation sequencing technology to analyze multiple genes at once, providing a comprehensive analysis of an individual’s genetic makeup.

Identification of a CA8 gene mutation can help with the diagnosis of CAMRQ3 and can also provide information about the inheritance pattern of the disorder. This information can be useful for genetic counseling and family planning.

Early diagnosis and management of CAMRQ3 can improve outcomes and quality of life for affected individuals. Treatment may include physical therapy, speech therapy, and educational interventions tailored to the individual’s specific needs.

SKU: TEST-1144 Category:

Related products